LeonaBio, Inc. Other Comprehensive Income (Loss), Net of Tax
LeonaBio, Inc. (LONA) reported Other Comprehensive Income (Loss), Net of Tax of -$33.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2021-11-10
- LeonaBio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2021-09-30 was -$33.00K, a 571.43% decline year-over-year.
- LeonaBio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2021-06-30 was $9.00K.
- LeonaBio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2021-03-31 was -$5.00K.
- LeonaBio, Inc. other comprehensive income (loss), net of tax for the quarter ending 2020-12-31 was $26.00K.
- LeonaBio, Inc. other comprehensive income (loss), net of tax for fiscal 2020 was $33.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$33.00K 10-Q · filed 2021-11-10 | -$24.00K derived: sum of 2 quarters · filed 2021-11-10 | -$29.00K derived: sum of 3 quarters · filed 2021-11-10 | -$3.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $9.00K 10-Q · filed 2021-11-10 | $4.00K derived: sum of 2 quarters · filed 2021-11-10 | $30.00K derived: sum of 3 quarters · filed 2021-11-10 | $37.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | -$5.00K 10-Q · filed 2021-11-10 | $21.00K derived: sum of 2 quarters · filed 2021-11-10 | $28.00K derived: sum of 3 quarters · filed 2021-11-10 | |
| 2020-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $33.00K derived: sum of 2 quarters · filed 2021-11-10 | $33.00K 10-K · filed 2021-03-25 | |
| 2020-09-30 | $7.00K 10-Q · filed 2021-11-10 | $7.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |